UK includes nerve condition as uncommon side-effect of AstraZeneca COVID-19 vaccine By Reuters

© Reuters. SUBMIT PICTURE: A medical employee prepares a dosage of AstraZeneca COVID-19 vaccine at a vaccination center, in the middle of the coronavirus illness break out, in Ronquieres, Belgium April 6, 2021. REUTERS/Yves Herman

(Reuters) – The UK drug regulator included an incredibly uncommon nerve-damaging condition, Guillain-Barré syndrome (GBS), as a really uncommon adverse effects of the AstraZeneca (NASDAQ:) COVID-19 vaccine, updates on the company’s site revealed on Thursday.

Medicines and Healthcare items Regulatory Agency’s (MHRA) choice follows the European medications company included GBS as a possible side-effect last month.

Disclaimer: Fusion Media want to advise you that the information consisted of in this site is not always real-time nor precise. All CFDs (stocks, indexes, futures) and Forex costs are not supplied by exchanges however rather by market makers, therefore costs might not be precise and might vary from the real market value, suggesting costs are a sign and not proper for trading functions. Therefore Fusion Media doesn`t bear any duty for any trading losses you may sustain as an outcome of utilizing this information.

Fusion Media or anybody included with Fusion Media will decline any liability for loss or damage as an outcome of dependence on the info consisting of information, quotes, charts and buy/sell signals consisted of within this site. Please be completely notified concerning the threats and expenses connected with trading the monetary markets, it is among the riskiest financial investment kinds possible.


News and digital media editor, writer, and communications specialist. Passionate about social justice, equity, and wellness. Covering the news, viewing it differently.

Related Articles

Back to top button

Adblock Detected

Please turn off the Adblocker